Targeting antioxidant enzymes enhances the therapeutic efficacy of the BCL-X-L inhibitor ABT-263 in KRAS-mutant colorectal cancers
- Publisher
- CANCER LETTERS
- Language
- 영어
- ISSN
- 0304-3835
- Citation Volume
- 497
- Citation Start Page
- 123
- Citation End Page
- 136
-
Appears in Collections:
- Medicine > Medicine
- Authorize & License
-
- Files in This Item:
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.